Concepedia

Publication | Closed Access

Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab

64

Citations

25

References

2013

Year

Abstract

Interleukin-6 (IL-6) blocking therapy with tocilizumab did not affect the humoral immune response to both influenza and pneumococcal vaccines.

References

YearCitations

Page 1